Novartis Investigative Site

Willingboro, New Jersey 08046

0 studies enrolling now · 2 studies all time

What they study most

Attention Deficit/Hyperactivity Disorder, Major Depressive Disorder

Studies at this site

• A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) — Completed
• Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD) — Completed